- Study Confirms Minorities Face Higher Odds of COVID-19: Study
- Lockdown Could Worsen Hearing Woes for U.S. Seniors
- Women Get Worse Care for Heart Attack
- Global Death Toll From COVID-19 Passes One Million
- Health Highlights: Sept. 29, 2020
- Preparing for Flooding During Hurricane Season
- How You Can Help Prevent Suicide During the COVID-19 Pandemic
- ‘Silent’ COVID-19 Produces as Much Virus as in Patients With Symptoms: Study
- Immune System Clues to Why COVID Is Easier on Kids
- Is Shock Therapy Making a Comeback Against Bipolar Disorder?
Clinical Trials Update: April 5, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Moderate or Severe Pain from Osteoarthritis (OA) of the Hip or Knee
This study of an investigational pain medication seeks people 18 or older who have osteoarthritis of the hip or knee.
The study sites are located nationwide.
More information
Please see http://www.clinicalconnection.com/7499.aspx.
—–
Healthy Male Volunteers (Ages 21-50)
The study involves taking two FDA-approved antidepressants and an inactive placebo for two weeks each. There are three brain MRI scans during the study, which will last about 12 weeks.
The research site is in Brighton, Mass.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/healthy_volunteers.aspx.
—–
Hot Flashes
To qualify for this study, female volunteers must be aged 18 to 70 and have moderate-to-severe hot flashes.
The research site is in DeLand, Fla.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/hot_flashes.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
